Skip to Content

Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted).

Licence status
Authorised: 21/03/2018
Active substances
Recombinant varicella zoster virus surface glycoprotein e
Dosage Form
Powder and suspension for suspension for injection
Licence number
EU/1/18/1272/001-002
Licence holder
GlaxoSmithKline Biologicals S.A.

Licence information

ATC code
J07BK Varicella zoster vaccines, J07BK03 Zoster, Purified Antigen
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
21/03/2018